• Register
  • Login

European Journal of Molecular & Clinical Medicine

  • Home
  • Browse
    • Current Issue
    • By Issue
    • By Subject
    • Keyword Index
    • Author Index
    • Indexing Databases XML
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Publication Ethics
    • Indexing and Abstracting
    • Peer Review Process
    • News
  • Guide for Authors
  • Submit Manuscript
  • Contact Us
Advanced Search

Notice

As part of Open Journals’ initiatives, we create website for scholarly open access journals. If you are responsible for this journal and would like to know more about how to use the editorial system, please visit our website at https://ejournalplus.com or
send us an email to info@ejournalplus.com

We will contact you soon

  1. Home
  2. Volume 8, Issue 3
  3. Author

Online ISSN: 2515-8260

Volume8, Issue3

Autophagy as a molecular target for cancer treatment

    Raghad Abdulsalam Khaleel

European Journal of Molecular & Clinical Medicine, 2021, Volume 8, Issue 3, Pages 1946-1962

  • Show Article
  • Download
  • Cite
  • Statistics
  • Share

Abstract

Autophagy is a progressive conserved catabolic mechanism, by which eukaryotic cells recycle or degrades internal constituents through the membrane-trafficking pathway. Thus, autophagy provides the cells with a sustainable source of biomolecules and energy for the maintenance of homeostasis under stressful conditions such as tumor microenvironment.It is generally believed that modulating autophagic activity, through targeting specific regulatory actors in the core autophagy machinery, may impact disease processes. Both autophagy upregulation and down regulation have been found in cancers, suggesting its dual oncogenic and tumor suppressor properties during malignant transformation. Identification of the key autophagy targets is essential for the development of new therapeutic agents. In this review the two-faced role of autophagy in cancer as a tumor suppressor or as a pro-oncogenic mechanism discussed and the shared regulatory pathways that play a role in autophagy and malignant transformationillustrated. Finally, anti-cancer therapeutic agents used as either inhibitors or inducers of autophagy have been discussed.
Keywords:
    Autophagy is a progressive conserved catabolic mechanism by which eukaryotic cells recycle or degrades internal constituents through the membrane-trafficking pathway
  • PDF (661 K)
  • XML
(2021). Autophagy as a molecular target for cancer treatment. European Journal of Molecular & Clinical Medicine, 8(3), 1946-1962.
Raghad Abdulsalam Khaleel. "Autophagy as a molecular target for cancer treatment". European Journal of Molecular & Clinical Medicine, 8, 3, 2021, 1946-1962.
(2021). 'Autophagy as a molecular target for cancer treatment', European Journal of Molecular & Clinical Medicine, 8(3), pp. 1946-1962.
Autophagy as a molecular target for cancer treatment. European Journal of Molecular & Clinical Medicine, 2021; 8(3): 1946-1962.
  • RIS
  • EndNote
  • BibTeX
  • APA
  • MLA
  • Harvard
  • Vancouver
  • Article View: 197
  • PDF Download: 401
  • LinkedIn
  • Twitter
  • Facebook
  • Google
  • Telegram
Journal Information

Publisher:

Email:  editor.ejmcm21@gmail.com

  • Home
  • Glossary
  • News
  • Aims and Scope
  • Privacy Policy
  • Sitemap

 

For Special Issue Proposal : editor.ejmcm21@gmail.com

This journal is licensed under a Creative Commons Attribution 4.0 International (CC-BY 4.0)

Powered by eJournalPlus